Published in Aesthetic Plast Surg on March 11, 2005
Nonmedical-grade Injections of Permanent Fillers: Medical and Medicolegal Considerations. J Clin Aesthet Dermatol (2013) 1.55
Complications from injectable materials used for breast augmentation. Can J Plast Surg (2009) 1.51
Radiolabelled white blood cell scintigraphy in the work-up of dermal filler complications. Eur J Nucl Med Mol Imaging (2012) 1.41
Probable biofilm formation in the cheek as a complication of soft tissue filler resulting from improper endodontic treatment of tooth 16. Int J Nanomedicine (2012) 0.99
Periurethral abscess following polyacrylamide hydrogel (Bulkamid) for stress urinary incontinence. Int Urogynecol J (2012) 0.97
Fillers: contraindications, side effects and precautions. J Cutan Aesthet Surg (2010) 0.83
Injectable gelatin derivative hydrogels with sustained vascular endothelial growth factor release for induced angiogenesis. Acta Biomater (2014) 0.79
Conducting polymer-hydrogels for medical electrode applications. Sci Technol Adv Mater (2010) 0.78
Aesthetic surgery of the male genitalia. Semin Plast Surg (2011) 0.77
Silicone Granulomas, a Growing Problem? J Clin Aesthet Dermatol (2016) 0.77
Facial gel complication after dental injection: a case report. Craniomaxillofac Trauma Reconstr (2013) 0.75
Facial aesthetic correction with injectable poly-L-lactic Acid following removal of malar cheek implants. J Clin Aesthet Dermatol (2009) 0.75
Etiology, Prevention, and Management of Infectious Complications of Dermal Fillers. Semin Plast Surg (2016) 0.75
A new model for in vitro testing of vitreous substitute candidates. Graefes Arch Clin Exp Ophthalmol (2014) 0.75
Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst (2008) 5.82
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol (2012) 5.70
Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet (2010) 4.51
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet (2009) 4.38
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet (2010) 3.86
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst (2014) 2.40
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2007) 1.92
Primary mucinous carcinoma of the skin. Am J Dermatopathol (2007) 1.66
Short-term functional and oncologic outcomes of nephron-sparing surgery for renal tumours ≥ 7 cm. Eur Urol (2011) 1.63
Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations. Cardiovasc Res (2003) 1.61
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas. Gynecol Oncol (2013) 1.61
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2009) 1.59
Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients. Clin Cancer Res (2011) 1.47
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer (2013) 1.47
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". PLoS Genet (2010) 1.47
Polymorphisms in DNA repair genes and epithelial ovarian cancer risk. Int J Cancer (2005) 1.44
Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Hum Mol Genet (2009) 1.42
Common variants in mismatch repair genes and risk of invasive ovarian cancer. Carcinogenesis (2006) 1.35
Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set. Cancer Epidemiol Biomarkers Prev (2007) 1.34
Whole genome amplification on DNA from filter paper blood spot samples: an evaluation of selected systems. Genet Test (2007) 1.30
Is there a need to further subclassify pT2 renal cell cancers as implemented by the revised 7th TNM version? Eur Urol (2010) 1.26
One third of Danish hypertrophic cardiomyopathy patients with MYH7 mutations have mutations [corrected] in MYH7 rod region. Eur J Hum Genet (2005) 1.25
Detection of bacteria by fluorescence in situ hybridization in culture-negative soft tissue filler lesions. Dermatol Surg (2009) 1.23
The effects of common genetic variants in oncogenes on ovarian cancer survival. Clin Cancer Res (2008) 1.21
Primary mucinous carcinoma of the skin: a population-based study. Int J Dermatol (2008) 1.18
STK15 polymorphisms and association with risk of invasive ovarian cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.18
Genetic and phenotypic characterization of mutations in myosin-binding protein C (MYBPC3) in 81 families with familial hypertrophic cardiomyopathy: total or partial haploinsufficiency. Eur J Hum Genet (2004) 1.16
Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients. BMC Cancer (2012) 1.14
ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiol Biomarkers Prev (2010) 1.08
Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer. PLoS One (2007) 1.08
Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival. Clin Cancer Res (2008) 1.04
Reversible switching between p- and n-type conduction in the semiconductor Ag10Te4Br3. Nat Mater (2009) 1.03
Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer Epidemiol Biomarkers Prev (2013) 1.02
Common variants in RB1 gene and risk of invasive ovarian cancer. Cancer Res (2006) 1.01
Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 1.01
Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer. Cancer Res (2008) 1.00
Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers. Neoplasia (2010) 0.99
Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma--a multicentre study. Eur J Cancer (2012) 0.97
Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium. Int J Cancer (2011) 0.95
Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival. Hum Mol Genet (2009) 0.94
Differential kinetics of effector and regulatory T cells in patients on calcineurin inhibitor-based drug regimens. Kidney Int (2009) 0.93
Validation of epithelial ovarian cancer and fallopian tube cancer and ovarian borderline tumor data in the Danish Gynecological Cancer Database. Acta Obstet Gynecol Scand (2009) 0.92
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer Epidemiol Biomarkers Prev (2013) 0.92
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst (2015) 0.90
Capillary electrophoresis-based single strand DNA conformation analysis in high-throughput mutation screening. Hum Mutat (2003) 0.90
Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Res (2013) 0.89
Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. Cancer Epidemiol Biomarkers Prev (2008) 0.89
Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology. Acta Obstet Gynecol Scand (2009) 0.89
K-ras alterations in Danish ovarian tumour patients. From the Danish "Malova" Ovarian Cancer study. Gynecol Oncol (2003) 0.87
Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish "Malova" Ovarian Cancer Study. Anticancer Res (2003) 0.87
Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk. Hum Mol Genet (2011) 0.85
Identification and molecular characterization of the gene encoding coli surface antigen 20 of enterotoxigenic Escherichia coli. FEMS Microbiol Lett (2004) 0.85
Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients. Anticancer Res (2002) 0.85
da Vinci and Open Radical Prostatectomy: Comparison of Clinical Outcomes and Analysis of Insurance Costs. Urol Int (2015) 0.85
Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev (2010) 0.84
High-throughput single strand conformation polymorphism mutation detection by automated capillary array electrophoresis: validation of the method. Hum Mutat (2003) 0.82
Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients. Eur J Cancer (2008) 0.82
Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome. Cancer Immunol Res (2014) 0.82
Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor size. Virchows Arch (2014) 0.81
Management of postoperative complications of breast augmentation by injected polyacrylamide hydrogel. Aesthetic Plast Surg (2006) 0.80
Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk. Obstet Gynecol (2016) 0.80
Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort. Fertil Steril (2010) 0.79
Bacterial infection as a likely cause of adverse reactions to polyacrylamide hydrogel fillers in cosmetic surgery. Clin Infect Dis (2013) 0.79
P53 mutations in tissue from Danish ovarian cancer patients: from the Danish "MALOVA" ovarian cancer study. Gynecol Oncol (2005) 0.76
Complications induced by polyacrylamide hydrogen injection. Plast Reconstr Surg (2005) 0.75
Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet (2015) 0.75
Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma. BMC Cancer (2014) 0.75
Quality of Preoperative Biopsy Is a Risk Factor for Positive Surgical Margins in Organ-Confined Prostate Cancer Treated with Nerve-Sparing Robot-Assisted Radical Prostatectomy. Urol Int (2015) 0.75
Optimization of capillary array electrophoresis single-strand conformation polymorphism analysis for routine molecular diagnostics. Electrophoresis (2006) 0.75
Single-strand conformation polymorphism analysis using capillary electrophoresis. Curr Protoc Hum Genet (2003) 0.75
In vitro activities of levofloxacin, gatifloxacin, moxifloxacin and garenoxacin against Bacteroides fragilis strains evaluated by kill kinetics. J Med Microbiol (2013) 0.75
Self-reported diseases and symptoms by rupture status among unselected Danish women with cosmetic silicone breast implants. Plast Reconstr Surg (2003) 0.75